| Alexandra Claflin, | |
|
1387 Fairport Rd, Building 1100, Fairport, NY 14450-2003 | |
| (585) 641-0304 | |
| (585) 641-0316 |
| Full Name | Alexandra Claflin |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 10 Years |
| Location | 1387 Fairport Rd, Fairport, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043681760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 038011-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nysarc Inc | 4486749751 | 11 |
News Archive
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60 %.
The most abundant and important molecules in all living organisms are proteins; after all they manage to participate in every single one of life's essential reactions. So it is easy to see why scientists have been making such a fuss trying to learn how to synthesise them in laboratory as this would provide them with a tool of extraordinary potential. Unfortunately, this has not proved easy.
Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
› Verified 8 days ago
| Provider Name | Nysarc Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457458424 PECOS PAC ID: 4486749751 Enrollment ID: O20071002000071 |
News Archive
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60 %.
The most abundant and important molecules in all living organisms are proteins; after all they manage to participate in every single one of life's essential reactions. So it is easy to see why scientists have been making such a fuss trying to learn how to synthesise them in laboratory as this would provide them with a tool of extraordinary potential. Unfortunately, this has not proved easy.
Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Claflin, 2060 Brighton Henrietta Town Line Rd, Rochester, NY 14623-2792 Ph: () - | Alexandra Claflin, 1387 Fairport Rd, Building 1100, Fairport, NY 14450-2003 Ph: (585) 641-0304 |
News Archive
Helsinn Group and Eisai Inc. announced today that Helsinn has commenced a multi-centered Phase III clinical study program investigating the Netupitant/Palonosetron (300mg/0.50mg) oral fixed-dose combination for the prevention of chemotherapy-induced nausea and vomiting.
Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60 %.
The most abundant and important molecules in all living organisms are proteins; after all they manage to participate in every single one of life's essential reactions. So it is easy to see why scientists have been making such a fuss trying to learn how to synthesise them in laboratory as this would provide them with a tool of extraordinary potential. Unfortunately, this has not proved easy.
Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Sangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b double-blind, placebo-controlled clinical trial (SB-509-901) in subjects with diabetic neuropathy (DN). The company expects to have efficacy data from this study in the second half of 2011. The company also plans to present the first human clinical data from its Phase 1 trials of SB-728-T in HIV/AIDS in the first quarter of 2011.
› Verified 8 days ago
Star Physical Therapy Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 790 Ayrault Road, Fairport, NY 14450 Phone: 585-425-1018 Fax: 585-425-8955 | |
Dr. Heather Michele Chatt, DPT, OCS, CERT. MDT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 790 Ayrault Rd, Fairport, NY 14450 Phone: 585-425-1018 | |
Amy Colin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 149 N Main St, Bright Start Pediatric Services, Fairport, NY 14450 Phone: 585-377-2230 | |
Lauren Elizabeth Porzi, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4646 Fairport Nine Mile Pt Rd, Fairport, NY 14450 Phone: 585-377-0350 | |
Dr. Rodrigo Macias Jr., DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4646 Fairport Nine Mile Pt Rd, Fairport, NY 14450 Phone: 909-419-6606 | |
Mrs. Allison Beth Kling Simonian, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 790 Ayrault Rd, Fairport, NY 14450 Phone: 585-425-1018 Fax: 585-425-8955 |